Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
When time is of the essence, knowing ways to get emergency cash quickly can make a difference. Explore your options.
23,900 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Global regulators are tightening the rules around AI financing as investment soars, signaling potential shifts in fun...
A senior was targeted by scammers posing as trusted representatives, leading to substantial account withdrawals. This...
Early 2026 shows Asia-led gains outpacing the U.S., with Asia-focused ETFs rising as tech and earnings momentum impro...
Bitcoin slipped below $67,000 on Sunday, testing a key level as Pi Network's PI tumbled after a sharp rally. Traders ...
Alphabet and Meta delivered divergent Q4 results, underscoring different paths to durable profits. Cloud, AI, and cap...
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Gap's Athleta unit remains a stalemate for the parent company, with a slow recovery in yoga-wear that raises question...
Apple’s shares tumbled after WWDC-style AI updates raised questions about iPhone upgrades and monetization. This guid...
Retail buzz around Celsius, Chewy, and Estée Lauder is pulsing through markets as earnings shape the near-term outloo...
MicroStrategy is monetizing BTC to back dividends and bolster liquidity, draining a portion of its planned sale capac...
Momentum can tilt a portfolio toward recent winners. This article explains how two Vanguard ETFs using momentum aim t...